On Wednesday, Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s shares inclined 0.98% to $262.52.
Eyegate Pharmaceuticals, Inc. (EYEG) a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, recently declared that it has reached an exclusive, worldwide licensing agreement with a partner of Valeant Pharmaceuticals International, Inc. (VRX) through which EyeGate has granted Valeant exclusive, worldwide commercial and manufacturing rights to its EyeGate(R) II Delivery System and EGP-437 combination product (“Product”) in the field of uveitis, in addition to a right of last negotiation to license the Product for other indications.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer. I
Splunk Inc (NASDAQ:SPLK)’s shares gained 1.76% to $69.31.
Splunk Inc. (SPLK), provider of the leading software platform for real-time Operational Intelligence, will report results for its fiscal second quarter ended July 31, 2015 on Thursday, August 27, 2015. The results will be comprised of in a press release with accompanying financial information that will be released after market close and posted on the Splunk Investor Relations website.
Splunk, Inc. provides software products that enable organizations to gain real-time operational intelligence in the United States and internationally. The company’s products enable users to collect, index, search, explore, monitor, and analyze data regardless of format or source users. It offers Splunk Enterprise, a machine data engine with collection, indexing, search, reporting analysis, alerting, monitoring, and data administration capabilities; and Splunk Cloud service.
At the end of Wednesday’s trade, Toronto-Dominion Bank (NYSE:TD)‘s shares surged 0.62% to $40.34.
Thanks to its customers, recently TD Canada Trust is celebrating a 10 year milestone. Based on customer feedback, the bank has again been recognized by J.D. Power as the “Highest in Customer Satisfaction among the Big Five Retail Banks” for the tenth successive year.
As the needs and expectations of customers have evolved, TD has adapted to reflect how customers want to interact with their bank, notably through introducing a host of digital enhancements such as a redesign of its smartphone app, digital imaging enhancements to its ATM network, providing customer support through SMS and social media channels, and introducing an online live-chat service. Hockey adds, “Whether our employees are in our branches providing financial advice, or providing support through our phone and online channels, customer service is so deeply embedded in the culture, it’s a part of our DNA. My commitment to our customers is that we are going to continue to raise the bar to deliver legendary experiences.”
In addition to this latest J.D. Power award, TD Small Business Banking also was recognized as “Highest in Customer Satisfaction with Small Business Banking” in the annual J.D. Power Canadian Small Business Banking Customer Satisfaction Study.
The Toronto-Dominion Bank, together with its auxiliaries, provides financial and banking services in North America and internationally. The company operates through Canadian Retail, U.S. Retail, and Wholesale Banking segments. The Canadian Retail segment offers various financial products and services, in addition to telephone, Internet, and mobile banking services to about 15 million personal and small business customers through a network of 1,165 branches and 2,867 automated banking machines in Canada.
Government Properties Income Trust (NYSE:GOV), ended its Wednesday’s trading session with -2.86% loss, and closed at $16.63.
Government Properties Income Trust (GOV) declared its financial results for the quarter and six months ended June 30, 2015.
David Blackman, President and Chief Operating Officer of GOV, made the following statement:
Results for the Quarter Ended June 30, 2015:
Normalized funds from operations, or Normalized FFO, for the quarter ended June 30, 2015 were $42.4 million, or $0.60 per diluted share, contrast to Normalized FFO for the quarter ended June 30, 2014 of $31.5 million, or $0.57 per diluted share. The enhance in Normalized FFO per share this quarter was primarily the result of GOV’s investment in Select Income REIT (SIR).
Net loss determined in accordance with U.S. generally accepted accounting principles, or GAAP, was $191.2 million, or $2.71 per diluted share, for the quarter ended June 30, 2015, contrast to net income of $14.6 million, or $0.27 per diluted share, for the quarter ended June 30, 2014. The net loss for the quarter ended June 30, 2015 comprised of a non-cash loss on impairment of GOV’s investment in SIR of $203.3 million, or $2.88 per diluted share. The weighted average number of diluted common shares outstanding was 70.5 million for the quarter ended June 30, 2015, and 54.7 million for the quarter ended June 30, 2014.
Government Properties Income Trust is a real estate investment trust (REIT). The Company operates in two business segments: ownership of properties that are primarily leased to Government tenants and its equity method investment in Select Income REIT (SIR). The Company’s properties are located in Alabama, Arizona, California, Florida, Kentucky, Massachusetts, New Jersey, New York, Texas, Washington and Wyoming.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
